Statement Of Cash Flows

DAIKEN MEDICAL CO.,LTD - Filing #7541406

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
750,156,000 JPY
604,978,000 JPY
Depreciation
104,185,000 JPY
146,240,000 JPY
Interest and dividend income
0 JPY
0 JPY
Interest expenses
2,407,000 JPY
1,971,000 JPY
Decrease (increase) in trade receivables
-53,463,000 JPY
-74,569,000 JPY
Decrease (increase) in inventories
-63,245,000 JPY
-109,998,000 JPY
Increase (decrease) in trade payables
18,173,000 JPY
22,697,000 JPY
Subtotal
802,293,000 JPY
546,090,000 JPY
Other, net
-42,339,000 JPY
-10,002,000 JPY
Income taxes paid
-197,086,000 JPY
-195,526,000 JPY
Net cash provided by (used in) operating activities
602,718,000 JPY
348,629,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-2,488,000 JPY
-1,934,000 JPY
Cash flows from operating activities
Increase (decrease) in accounts payable - other
47,331,000 JPY
-7,742,000 JPY
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
-110,958,000 JPY
-103,087,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-110,942,000 JPY
-104,033,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
0 JPY
Dividends paid
-315,557,000 JPY
-306,762,000 JPY
Repayments of long-term borrowings
-229,986,000 JPY
-368,238,000 JPY
Net cash provided by (used in) financing activities
-350,481,000 JPY
-480,658,000 JPY
Net increase (decrease) in cash and cash equivalents
141,294,000 JPY
-236,061,000 JPY
Cash and cash equivalents
2,657,507,000 JPY
2,516,212,000 JPY
2,282,527,000 JPY
2,518,589,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.